Skip to main content

(Approval lapsed) Acetazolamide for injection, USP 500 mg (Mylan USA)

Section 19A approved medicine
(Approval lapsed) Acetazolamide for injection, USP 500 mg (Mylan USA)
Section 19A approval holder
Phebra Pty Ltd ABN 99 059 357 890
Phone
1800 720 020
Approved until
Status
Expired
Medicines in short supply/unavailable
GLAUMOX acetazolamide (as sodium) 500 mg powder for injection vial - ARTG 142075
Indication(s)

For adjunctive treatment of: oedema due to congestive heart failure; drug-induced oedema; entrencephalic epilepsies (petit mal, unlocalised seizures); chronic simple (open-angle) glaucoma, secondary glaucoma and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure.

Images
Picture of Acetazolamide for injection, USP 500 mg (Mylan USA)

Help us improve the Therapeutic Goods Administration site